Allurion Technologies, Inc. Net Change in Cash
Allurion Technologies, Inc. (ALUR) reported Net Change in Cash of -$355.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2026-05-15
- Allurion Technologies, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2026-03-31 was -$355.00K, a 107.06% decline year-over-year.
- Allurion Technologies, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-03-31 was $5.03M.
- Allurion Technologies, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was -$8.35M, a 467.81% decline year-over-year.
- Allurion Technologies, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was $2.27M.
- Allurion Technologies, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2025 was -$9.98M.
- Allurion Technologies, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was -$22.70M, a 174.69% decline from fiscal 2023.
- Allurion Technologies, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was $30.40M.
- Allurion Technologies, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$17.99M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$355.00K 10-Q · filed 2026-05-15 | |||
| 2025-12-31 | -$9.98M 10-K · filed 2026-03-30 | |||
| 2025-09-30 | -$9.25M 10-Q · filed 2025-11-17 | |||
| 2025-06-30 | -$2.65M 10-Q · filed 2025-08-19 | |||
| 2025-03-31 | $5.03M 10-Q · filed 2026-05-15 | |||
| 2024-12-31 | -$22.70M 10-K · filed 2026-03-30 | |||
| 2024-09-30 | -$9.38M 10-Q · filed 2025-11-17 | |||
| 2024-06-30 | -$18.77M 10-Q/A · filed 2025-08-28 | |||
| 2024-03-31 | -$8.35M 10-Q/A · filed 2025-08-28 | |||
| 2023-12-31 | $30.40M 10-K/A · filed 2025-08-28 | |||
| 2023-09-30 | $72.08M 10-Q/A · filed 2025-08-28 | |||
| 2023-06-30 | -$2.92M 10-Q/A · filed 2025-08-28 | |||
| 2023-03-31 | $2.27M 10-Q/A · filed 2025-08-28 | |||
| 2022-12-31 | -$17.99M 10-K/A · filed 2025-08-28 | |||
| 2022-09-30 | -$16.45M 10-Q · filed 2023-11-14 | |||
| 2022-06-30 | -$16.27M 10-Q · filed 2023-10-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |